Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement.
The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter from C$136.13 million in the third quarter. The deterioration in the bottom-line performance reflects a 5% decrease in revenues to C$72.1 million.
Shares of Aurora Cannabis closed Tuesday’s regular session higher in the New York Stock Exchange but decreased during the extended trading session. The stock, which has been on a losing streak for several months, has lost about 70% so far this year.
Most Popular
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and
AMAT Stock: Is now the right time to invest in Applied Materials?
It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied
Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year
Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the
